SUBSTITUTED QUINOLINE COMPOUNDS

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in...

Full description

Saved in:
Bibliographic Details
Main Authors EWING, MARCUS DOUGLAS, BERTINATO, PETER, ROBINSON, RALPH PELTON, JR, HAMANAKA, ERNEST SEIICHI, TICKNER, DEREK LAWRENCE, COUTURIER, MICHEL ANDRE
Format Patent
LanguageEnglish
French
German
Published 02.11.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.
Bibliography:Application Number: EP20050702327